A blood gas test measures the amount of oxygen and carbon dioxide in the blood. It is also used to determine the pH and acidic content of the blood. The test is commonly known as a blood gas analysis or arterial blood gas (ABG) test. Imbalances in the oxygen, carbon dioxide, and pH levels of your blood indicate the presence of certain medical conditions. These products are used in emergency departments for the diagnosis of various diseases including kidney failure, heart failure, uncontrolled diabetes, hemorrhage, chemical poisoning, a drug overdose, shock, asthma, and chronic obstructive pulmonary disorder (COPD).
The global blood gas and electrolyte analyzers market was valued at $1,427 million in 2016, and is estimated to garner $2,104 million by 2023, registering a CAGR of 5.7% from 2017 to 2023. The major factors that enhance the market growth are growth in number of patients being treated in ICUs, NICUs, and emergency departments; rise in patients suffering from chronic diseases; and increase in number of product approvals. However, complexity involved in interpretation of data acts as a restraining factor for the market growth.
The global blood gas and electrolyte analyzers market is segmented by type, product/brand, end user, and geography. Based on type, it is classified into analyzers/instruments and consumables. Analyzers/instruments is further sub segmented into product type and modality. Based on product type, it is categorized into blood gas analyzers, electrolyte analyzers, and combined analyzers. Based on modality, it is divided into laboratory, benchtop, and portable.
By product/brand, it is classified into i-Stat, ePOC, GEM Premier, ABL Flex, Cobas, RAPID Series, and other blood gas analyzer. Based on end user, it is categorized into hospitals, clinics, ambulatory surgical centers(ASC), and others. Geographically, it is analyzed on the basis of four regions, namely, North America, Europe, Asia-Pacific, and LAMEA. The North America market accounted for significant share in the global market in 2016, owing to growth in number of patients admitted in the ICUs, NICUs, and emergency department.
KEY BENEFITS FOR STAKEHOLDERS
The study provides an in-depth analysis of the global blood gas and electrolyte analyzers market and the current trends and future estimations to elucidate the imminent investment pockets.
The report provides quantitative analysis of the industry from 2016 to 2023 to enable stakeholders to capitalize on the prevailing opportunities.
Extensive analysis of the market based on the type, product/brand, and end user elucidate the prevailing opportunities in these segments.
Comprehensive analysis of geographical regions is provided to determine the latent regional opportunities.
The key players operating and their strategies in the market are profiled to determine the competitive outlook of the market.
Blood Gas and Electrolyte Analyzers Market Key Segments:
BY TYPE
Analyzers/Instruments
Product Type
Blood Gas Analyzers
Electrolyte Analyzers
Combined Analyzers
Modality
Portable
Benchtop
Laboratory
Consumables
BY PRODUCT/BRAND
i-Stat (Abbott Laboratories)
ePOC (Alere, Inc.)
GEM Premier (Instrumentation Laboratory)
ABL Flex (Radiometer)
Cobas (Roche Diagnostics)
RAPID Series (Siemens Healthineers)
Others
BY END USER
Hospitals
Clinics
Ambulatory Surgical Centers(ASC)
Others
BY GEOGRAPHY
North America
U.S.
Canada
Mexico
Europe
UK
France
Germany
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Rest of Asia-Pacific
LAMEA
Latin America
Middle East
Africa
LIST OF KEY PLAYERS PROFILED IN THE REPORT
Radiometer Medical Aps (A Subsidiary of Danaher Corporation)
Instrumentation Laboratory (A Werfen Company)
Siemens AG
Roche Diagnostics Limited
Abbott Laboratories, Inc.
Nova Biomedical
OPTI Medical Systems, Inc. (A Subsidiary of Idexx Laboratories, Inc.)
ERBA Diagnostics Mannheim GmbH
Medica Corporation
Alere, Inc.
LIST OF OTHER PLAYERS IN THE VALUE CHAIN
(These players are not profiled in the report, but can be included on request)
Samsung Medison
Edan Instruments
Convergent Technologies
Dalko Diagnostics
Afford Medical Technologies
Accurex Biomedical Pvt. Ltd.
